Free Trial

Revvity (RVTY) Competitors

Revvity logo
$112.56 +2.02 (+1.83%)
(As of 12/20/2024 05:31 PM ET)

RVTY vs. KEYS, FTV, VLTO, TER, AVTR, BIO.B, VNT, NVMI, ST, and MIR

Should you be buying Revvity stock or one of its competitors? The main competitors of Revvity include Keysight Technologies (KEYS), Fortive (FTV), Veralto (VLTO), Teradyne (TER), Avantor (AVTR), Bio-Rad Laboratories (BIO.B), Vontier (VNT), Nova (NVMI), Sensata Technologies (ST), and Mirion Technologies (MIR). These companies are all part of the "measuring and control equipment" industry.

Revvity vs.

Keysight Technologies (NYSE:KEYS) and Revvity (NYSE:RVTY) are both large-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends, analyst recommendations, community ranking and media sentiment.

Keysight Technologies presently has a consensus target price of $180.80, indicating a potential upside of 10.77%. Revvity has a consensus target price of $132.47, indicating a potential upside of 17.69%. Given Revvity's higher possible upside, analysts clearly believe Revvity is more favorable than Keysight Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Keysight Technologies
1 Sell rating(s)
0 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.80
Revvity
0 Sell rating(s)
5 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.75

84.6% of Keysight Technologies shares are owned by institutional investors. Comparatively, 86.7% of Revvity shares are owned by institutional investors. 0.6% of Keysight Technologies shares are owned by company insiders. Comparatively, 0.6% of Revvity shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Keysight Technologies has a net margin of 12.32% compared to Revvity's net margin of 9.34%. Keysight Technologies' return on equity of 19.22% beat Revvity's return on equity.

Company Net Margins Return on Equity Return on Assets
Keysight Technologies12.32% 19.22% 10.52%
Revvity 9.34%7.42%4.40%

In the previous week, Keysight Technologies had 15 more articles in the media than Revvity. MarketBeat recorded 22 mentions for Keysight Technologies and 7 mentions for Revvity. Revvity's average media sentiment score of 1.06 beat Keysight Technologies' score of 0.97 indicating that Revvity is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Keysight Technologies
9 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Revvity
3 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Keysight Technologies received 447 more outperform votes than Revvity when rated by MarketBeat users. Likewise, 66.01% of users gave Keysight Technologies an outperform vote while only 59.52% of users gave Revvity an outperform vote.

CompanyUnderperformOutperform
Keysight TechnologiesOutperform Votes
472
66.01%
Underperform Votes
243
33.99%
RevvityOutperform Votes
25
59.52%
Underperform Votes
17
40.48%

Keysight Technologies has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.Comparatively, Revvity has a beta of 1.03, meaning that its stock price is 3% more volatile than the S&P 500.

Revvity has lower revenue, but higher earnings than Keysight Technologies. Keysight Technologies is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Keysight Technologies$4.98B5.68$614M$3.5046.63
Revvity$2.72B5.03$693.09M$2.0754.38

Summary

Keysight Technologies beats Revvity on 10 of the 18 factors compared between the two stocks.

Get Revvity News Delivered to You Automatically

Sign up to receive the latest news and ratings for RVTY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVTY vs. The Competition

MetricRevvityAnalytical instruments IndustryMedical SectorNYSE Exchange
Market Cap$13.70B$5.42B$5.10B$19.18B
Dividend Yield0.24%0.42%4.90%3.58%
P/E Ratio54.3825.1891.0841.22
Price / Sales5.034.291,113.5117.58
Price / Cash14.1244.4542.2621.28
Price / Book1.762.204.785.32
Net Income$693.09M$2.05M$119.77M$989.67M
7 Day Performance-2.92%-2.70%-1.87%-3.45%
1 Month Performance1.31%-2.89%11.46%-3.73%
1 Year Performance6.43%-28.70%30.53%12.06%

Revvity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVTY
Revvity
3.7588 of 5 stars
$112.56
+1.8%
$132.47
+17.7%
+8.2%$13.70B$2.72B54.3811,500Positive News
High Trading Volume
KEYS
Keysight Technologies
4.837 of 5 stars
$171.39
+2.9%
$180.80
+5.5%
+4.2%$29.74B$4.98B49.0414,900Analyst Revision
FTV
Fortive
4.779 of 5 stars
$76.80
-0.1%
$86.73
+12.9%
+4.0%$26.65B$6.20B30.5518,000Analyst Forecast
VLTO
Veralto
2.2593 of 5 stars
$104.61
+0.4%
$109.50
+4.7%
+29.3%$25.87B$5.02B32.4016,000Dividend Increase
TER
Teradyne
4.8644 of 5 stars
$129.88
+5.4%
$147.25
+13.4%
+21.6%$21.15B$2.68B39.126,500
AVTR
Avantor
4.9301 of 5 stars
$22.29
-0.2%
$27.69
+24.2%
-6.7%$15.17B$6.97B48.5414,500
BIO.B
Bio-Rad Laboratories
N/A$337.08
flat
N/A+6.6%$9.44B$2.67B-12.338,200
VNT
Vontier
3.2745 of 5 stars
$39.63
+0.1%
$44.44
+12.1%
+6.6%$5.95B$3.10B15.178,000
NVMI
Nova
3.0587 of 5 stars
$191.21
+1.5%
$227.80
+19.1%
+47.9%$5.55B$611.85M35.423,606Positive News
ST
Sensata Technologies
4.6792 of 5 stars
$30.29
-0.3%
$41.00
+35.4%
-25.3%$4.53B$4.05B-56.2419,400
MIR
Mirion Technologies
3.3203 of 5 stars
$18.76
+4.0%
$18.33
-2.3%
+76.2%$4.36B$836.90M-54.323,000Analyst Forecast
News Coverage
Positive News

Related Companies and Tools


This page (NYSE:RVTY) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners